Clinical Trial Update: Skin Sensitization Potential of a New Nicotine Patch [Phase 1]

View source ↗

Summary

A Phase 1 study update evaluating the skin sensitization potential of a new nicotine transdermal patch for smoking cessation. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Nicotine patch (nicotine patch)

Snippet

Sponsor: McNeil AB | Conditions: Smoking Cessation | Phase 1 | Status: COMPLETED